Chloe is an infectious diseases physician and clinical microbiologist who joined Burnet Institute in 2024 as a technical advisor in the AMR-One Health group.
She also works in infectious diseases and microbiology in Australian hospitals and is involved in research on antimicrobial resistance through the Wollongong Antimicrobial Resistance Research Alliance (WARRA).
Chloe has an interest in antimicrobial resistance, diagnostic stewardship, group A Streptococcal infections, microbial genomics, and development of microbiological services in low- and middle-income countries.
The Medical Journal of Australia
Amrita Ronnachit, Chloe Story, Chloe Story, Amrita Ronnachit, Chloe Story, Amrita Ronnachit
The Medical Journal of Australia
Amrita Ronnachit, Chloe Story, Chloe Story, Amrita Ronnachit, Chloe Story, Amrita Ronnachit
The Medical Journal of Australia
Amrita Ronnachit, Chloe Story, Chloe Story, Amrita Ronnachit, Chloe Story, Amrita Ronnachit
By 2050, antimicrobial resistant bacteria (AMR) could cause 10 million deaths annually. Our collaborative project supports Papua New Guinea’s domestic AMR response.
Burnet Institute is leading the Papua New Guinea Country Grant component of the Fleming Fund, a UK Aid program tackling antimicrobial resistance in low- and middle-income countries.